Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion type Assertion NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_head.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion description "[These findings suggest that epoetin alfa may provide a therapeutic benefit in patients with stroke, trauma, epilepsy, and other CNS-related disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_provenance.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion evidence source_evidence_literature NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_provenance.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion SIO_000772 15591419 NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_provenance.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion wasDerivedFrom befree-2016 NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_provenance.
- NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_assertion wasGeneratedBy ECO_0000203 NP472238.RA5Otj_Zr5yBFqF6Oox-RVxgSzUu3Al7lv63WMI-vbeC4130_provenance.